72 related articles for article (PubMed ID: 17260205)
1. Bone metastases in osteosarcoma patients treated with neoadjuvant or adjuvant chemotherapy: the Rizzoli experience in 52 patients.
Bacci G; Longhi A; Bertoni F; Briccoli A; Versari M; Pignotti E; Picci P
Acta Orthop; 2006 Dec; 77(6):938-43. PubMed ID: 17260205
[TBL] [Abstract][Full Text] [Related]
2. Osteosarcoma: the addition of muramyl tripeptide to chemotherapy improves overall survival--a report from the Children's Oncology Group.
Meyers PA; Schwartz CL; Krailo MD; Healey JH; Bernstein ML; Betcher D; Ferguson WS; Gebhardt MC; Goorin AM; Harris M; Kleinerman E; Link MP; Nadel H; Nieder M; Siegal GP; Weiner MA; Wells RJ; Womer RB; Grier HE;
J Clin Oncol; 2008 Feb; 26(4):633-8. PubMed ID: 18235123
[TBL] [Abstract][Full Text] [Related]
3. Clemastine and hyperthermia enhance sensitization of osteosarcoma cells for apoptosis.
Obu S; Niture S; Hoang H; Gadi S; Vandana ; He Y; Kumar D
Mol Cell Oncol; 2024; 11(1):2351622. PubMed ID: 38778919
[TBL] [Abstract][Full Text] [Related]
4. Nano-Based Drug Delivery Systems: Potential Developments in the Therapy of Metastatic Osteosarcoma-A Narrative Review.
Luo Y; Sun M; Tan L; Li T; Min L
Pharmaceutics; 2023 Dec; 15(12):. PubMed ID: 38140058
[TBL] [Abstract][Full Text] [Related]
5. Distinct genomic features between osteosarcomas firstly metastasing to bone and to lung.
Xie L; Cai Z; Lu H; Meng F; Zhang X; Luo K; Su X; Lei Y; Xu J; Lou J; Wang H; Du Z; Wang Y; Li Y; Ren T; Xu J; Sun X; Tang X; Guo W
Heliyon; 2023 May; 9(5):e15527. PubMed ID: 37205995
[TBL] [Abstract][Full Text] [Related]
6. Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma.
Lu KH; Lu PW; Lu EW; Lin CW; Yang SF
Int J Biol Sci; 2023; 19(4):1241-1265. PubMed ID: 36923933
[TBL] [Abstract][Full Text] [Related]
7. Comprehensive conservative treatment for multiple metastases of skull osteosarcoma: A case report.
Jiang D; Wang J; Chen Q; Wu J; Xu M; Yu X
Front Neurol; 2023; 14():1037673. PubMed ID: 36779058
[TBL] [Abstract][Full Text] [Related]
8. The Potential In Vitro Inhibitory Effects of Neurokinin-1 Receptor (NK-1R) Antagonist, Aprepitant, in Osteosarcoma Cell Migration and Metastasis.
Alsaeed MA; Ebrahimi S; Alalikhan A; Hashemi SF; Hashemy SI
Biomed Res Int; 2022; 2022():8082608. PubMed ID: 36177059
[TBL] [Abstract][Full Text] [Related]
9. How to confront the high prevalence of pulmonary micro nodules (PMNs) in osteosarcoma patients?
Cai Z; Xu J; Sun X; Zhang R; Xie L; Wang J; Tang X; Yang R; Guo W
Int Orthop; 2022 Oct; 46(10):2425-2436. PubMed ID: 35941258
[TBL] [Abstract][Full Text] [Related]
10. Prevalence, Risk Factors, and Prognostic Factors of Primary Malignant Bone Neoplasms with Bone Metastasis at Initial Diagnosis: A Population-Based Study.
Xiao ZW; Guo HL; Chen HC; Yan LP; Liao YL; Li SL; Zhao LL; Su LB; Li JJ; Tang FQ
J Oncol; 2022; 2022():9935439. PubMed ID: 35378768
[TBL] [Abstract][Full Text] [Related]
11. Curcumin in Osteosarcoma Therapy: Combining With Immunotherapy, Chemotherapeutics, Bone Tissue Engineering Materials and Potential Synergism With Photodynamic Therapy.
Xu C; Wang M; Guo W; Sun W; Liu Y
Front Oncol; 2021; 11():672490. PubMed ID: 34094974
[TBL] [Abstract][Full Text] [Related]
12. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
13. Maternal embryonic leucine zipper kinase serves as a poor prognosis marker and therapeutic target in osteosarcoma.
Jeddo SFA; Wei X; Li K; Li X; Yang Q; Dongol S; Li J
Oncol Rep; 2020 Sep; 44(3):1037-1048. PubMed ID: 32705239
[TBL] [Abstract][Full Text] [Related]
14. Management of Refractory Pediatric Sarcoma: Current Challenges and Future Prospects.
Pushpam D; Garg V; Ganguly S; Biswas B
Onco Targets Ther; 2020; 13():5093-5112. PubMed ID: 32606731
[TBL] [Abstract][Full Text] [Related]
15. 223-Radium for metastatic osteosarcoma: combination therapy with other agents and external beam radiotherapy.
Anderson PM; Scott J; Parsai S; Zahler S; Worley S; Shrikanthan S; Subbiah V; Murphy E
ESMO Open; 2020 Apr; 5(2):. PubMed ID: 32303572
[TBL] [Abstract][Full Text] [Related]
16. Hypoxia-Inducible Factor 1A Upregulates HMGN5 by Increasing the Expression of GATA1 and Plays a Role in Osteosarcoma Metastasis.
Xu E; Ji Z; Jiang H; Lin T; Ma J; Zhou X
Biomed Res Int; 2019; 2019():5630124. PubMed ID: 31930127
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of
Liu F; Zhang Q; Zhou D; Dong J
BMC Cancer; 2019 Apr; 19(1):323. PubMed ID: 30953476
[TBL] [Abstract][Full Text] [Related]
18. Combination of gemcitabine and docetaxel: a regimen overestimated in refractory metastatic osteosarcoma?
Xu J; Guo W; Xie L
BMC Cancer; 2018 Oct; 18(1):987. PubMed ID: 30326879
[TBL] [Abstract][Full Text] [Related]
19. Correlations Between Hector Battifora Mesothelial-1 (HBME-1) Expression and Clinical Pathological Characteristics and Prognosis of Osteosarcoma Patients.
Zhao YX; Gao ST; Wang JQ; Yao WT; Wang YS; Guo CL
Med Sci Monit; 2017 Feb; 23():665-672. PubMed ID: 28163298
[TBL] [Abstract][Full Text] [Related]
20. Osteosarcoma Overview.
Lindsey BA; Markel JE; Kleinerman ES
Rheumatol Ther; 2017 Jun; 4(1):25-43. PubMed ID: 27933467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
